In a patient with systemic lupus erythematosus who has low hemoglobin, low mean corpuscular volume, low iron saturation, low total iron‑binding capacity, and ferritin of 91 ng/mL, could this anemia be due to iron deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

This is NOT straightforward iron deficiency anemia – this is most likely anemia of chronic disease (ACD) with possible coexisting iron deficiency in the context of lupus.

Key Diagnostic Interpretation

The ferritin of 91.1 ng/mL in a lupus patient with inflammation makes pure iron deficiency anemia unlikely. In inflammatory conditions like SLE, ferritin acts as an acute phase reactant and can be falsely elevated, masking true iron deficiency 1, 2. The combination of:

  • Low iron saturation (11%)
  • Low TIBC (typically elevated in pure IDA)
  • Low MCV
  • Ferritin <100 ng/mL

...suggests functional iron deficiency or mixed ACD with iron deficiency rather than pure IDA.

Why This Matters in Lupus

The low TIBC is the critical distinguishing feature here. In pure iron deficiency, TIBC should be elevated as the body tries to capture more iron. A low TIBC indicates inflammation-driven anemia (ACD), where inflammatory cytokines suppress iron mobilization and erythropoiesis 3, 4.

Research specifically in SLE patients shows:

  • ACD is the most common anemia type (37-68% of cases) 5, 3
  • Pure IDA occurs in 16-36% 5, 3
  • Coexisting ACD + IDA occurs in up to 58% of cases 5
  • Ferritin underestimates iron deficiency in SLE because it's an acute phase reactant 5

Recommended Diagnostic Approach

Order soluble transferrin receptor (sTfR) or reticulocyte hemoglobin equivalent to definitively distinguish the anemia type 1, 5. These markers are not affected by inflammation and will reveal true iron deficiency:

  • Elevated sTfR = true iron deficiency present (either alone or coexisting with ACD)
  • Normal sTfR = pure ACD without iron deficiency
  • sTfR/log ferritin ratio >2 strongly suggests iron deficiency component 5

Clinical Correlation Needed

Check for:

  • Disease activity markers: ESR, CRP, anti-dsDNA, complement levels – these correlate with anemia severity in lupus 6, 7
  • Renal involvement: Lupus nephritis increases risk of both ACD and iron deficiency 6
  • GI blood loss: NSAIDs, anticoagulants, or occult bleeding can cause true iron deficiency
  • Hemolysis markers: Direct Coombs test, reticulocyte count, LDH, haptoglobin – autoimmune hemolytic anemia occurs in 14% of anemic SLE patients 3

Treatment Implications

Do not assume this is simple iron deficiency and start oral iron alone:

  • If sTfR confirms iron deficiency component: Consider IV iron rather than oral, as inflammatory state impairs oral iron absorption via hepcidin upregulation 1, 4, 7
  • If pure ACD: Focus on controlling lupus disease activity; iron supplementation won't help and may be harmful
  • If mixed picture: Treat both the inflammation and provide iron repletion (preferably IV) 5

Common Pitfall

The biggest mistake is assuming ferritin <100 ng/mL = iron deficiency in an inflammatory condition. In lupus, ferritin can be elevated by inflammation even when iron stores are depleted. The low TIBC is your red flag that inflammation is driving this anemia picture 2, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.